Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland

Shiri, 2005, Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting, Curr Opin Infect Dis, 18, 306, 10.1097/01.qco.0000171920.44809.f0 Bergogne-Bérézin, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features, Clin Microbiol Rev, 9, 148, 10.1128/CMR.9.2.148 El Shafie, 2004, Investigation of an outbreak of multidrug‐resistant Acinetobacter baumannii in trauma intensive care unit, J Hosp Infect, 56, 101, 10.1016/j.jhin.2003.09.024 Roberts, 2001, Investigation of an outbreak of multi‐drug resistant Acinetobacter baumannii in an intensive care burns unit, J Hosp Infect, 48, 228, 10.1053/jhin.2001.0985 Wang, 2003, Healthcare‐associated outbreak due to pan‐drug resistant Acinetobacter baumannii in a surgical intensive care unit, J Hosp Infect, 53, 97, 10.1053/jhin.2002.1348 Van Den Broek, 2006, Epidemiology of multiple Acinetobacter outbreaks in The Netherlands, Clin Microbiol Infect, 12, 837, 10.1111/j.1469-0691.2006.01510.x Davis, 2005, Multidrug‐resistant Acinetobacter extremity infections in soldiers, Emerg Infect Dis, 11, 1218, 10.3201/1108.050103 Jones, 2006, Importation of multidrug‐resistant Acinetobacter spp. infections with casualties from Iraq, Lancet Infect Dis, 6, 317, 10.1016/S1473-3099(06)70471-6 Turton, 2006, Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict, J Clin Microbiol, 44, 2630, 10.1128/JCM.00547-06 Hujer, 2006, Analysis of antibiotic resistance genes in multidrug‐resistant Acinetobacter isolates from military and civilian patients treated at the Walter Reed Army Medical Center, Antimicrob Agents Chemother, 50, 4114, 10.1128/AAC.00778-06 Friedland, 2003, Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a multicenter intensive care unit surveillance study, 1995–2000, Diagn Microbiol Infect Dis, 45, 245, 10.1016/S0732-8893(02)00503-5 Van Looveren, 2004, Antimicrobial resistance of Acinetobacter spp. in Europe, Clin Microbiol Infect, 10, 684, 10.1111/j.1469-0691.2004.00942.x Wróblewska, 2006, Novel therapies of multidrug‐resistant Pseudomonas aeruginosa and Acinetobacter spp. infections—a state of the art, Arch Immunol Ther Exp, 54, 113, 10.1007/s00005-006-0012-4 Poirel, 2006, Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology, Clin Microbiol Infect, 12, 826, 10.1111/j.1469-0691.2006.01456.x Hsueh, 2002, Pandrug‐resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan, Emerg Infect Dis, 8, 827, 10.3201/eid0805.020014 Michalopoulos, 2005, Cure of multidrug‐resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin, Scand J Infect Dis, 37, 142, 10.1080/00365540410020776-1 Fleischer, 2002, Comparative in vitro activity of carbapenems against Acinetobacter baumannii and Pseudomonas aeruginosa isolated from the intensive care unit, Clin Microbiol Infect, 8, 364 Stefaniuk, 2004, Phenotypic and genotypic characteristics of Acinetobacter spp. strains isolated from hospital infections, Med Dydak Wychow, 36, 50 Wroblewska, 2006, Multidrug‐resistant bacteria isolated from patients hospitalised in intensive care units, Int J Antimicrob Agents, 27, 285, 10.1016/j.ijantimicag.2005.11.015 Ehrenstein, 1996, Acinetobacter species identification by using tRNA spacer fingerprinting, J Clin Microbiol, 34, 2414, 10.1128/JCM.34.10.2414-2420.1996 NCCLS, 2001 NCCLS, 2003 Grundmann, 1997, Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR‐fingerprinting of Acinetobacter spp, J Clin Microbiol, 35, 3071, 10.1128/JCM.35.12.3071-3077.1997 Seifert, 2005, Standardization and interlaboratory reproducibility assessment of pulsed‐field gel electrophoresis‐generated fingerprints of Acinetobacter baumannii, J Clin Microbiol, 43, 4328, 10.1128/JCM.43.9.4328-4335.2005 Woodford, 2006, Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp, Int J Antimicrob Agents, 27, 351, 10.1016/j.ijantimicag.2006.01.004 Senda, 1996, PCR detection of metallo‐beta‐lactamase gene (blaIMP) in Gram‐negative rods resistant to broad‐spectrum beta‐lactams, J Clin Microbiol, 34, 2909, 10.1128/JCM.34.12.2909-2913.1996 Poirel, 2000, Characterization of VIM‐2, a carbapenem‐hydrolyzing metallo‐β‐lactamase and its plasmid‐ and integron‐borne gene from a Pseudomonas aeruginosa isolate in France, Antimicrob Agents Chemother, 44, 891, 10.1128/AAC.44.4.891-897.2000 Spence, 2004, Comparison of Acinetobacter baumannii isolates from United Kingdom hospitals with predominant northern European genotypes by amplified‐fragment length polymorphism analysis, J Clin Microbiol, 42, 832, 10.1128/JCM.42.2.832-834.2004 Cisneros, 2005, Risk‐factors for the acquisition of imipenem‐resistant Acinetobacter baumannii in Spain: a nationwide study, Clin Microbiol Infect, 11, 874, 10.1111/j.1469-0691.2005.01256.x Nemec, 2004, Long‐term predominance of two pan‐European clones among multi‐resistant Acinetobacter baumannii strains in the Czech Republic, J Med Microbiol, 53, 147, 10.1099/jmm.0.05445-0 Van Dessel, 2004, Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals, Res Microbiol, 155, 105, 10.1016/j.resmic.2003.10.003 Lee, 2004, Risk factors for acquisition of imipenem‐resistant Acinetobacter baumannii: a case‐control study, Antimicrob Agents Chemother, 48, 224, 10.1128/AAC.48.1.224-228.2004 Abbo, 2005, Multidrug‐resistant Acinetobacter baumannii, Emerg Infect Dis, 11, 22, 10.3201/eid1101.040001 Prashanth, 2006, Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors, Ind J Med Microbiol, 24, 39, 10.4103/0255-0857.19893 Richet, 2001, Building communication networks: international network for the study and prevention of emerging antimicrobial resistance, Emerg Infect Dis, 7, 319, 10.3201/eid0702.010235 Patzer, 2002, Susceptibility patterns of Gram‐negative bacteria from a Polish intensive care unit, 1997–2000, Int J Antimicrob Agents, 19, 431, 10.1016/S0924-8579(02)00018-3 Webster, 1999, Molecular and antibiogram relationships of Acinetobacter isolates from two contrasting hospitals in the United Kingdom and South Africa, Eur J Clin Microbiol Infect Dis, 18, 595, 10.1007/s100960050354 Turton, 2006, The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii, FEMS Microbiol Lett, 258, 72, 10.1111/j.1574-6968.2006.00195.x Lee, 2003, VIM‐ and IMP‐type metallo‐β‐lactamase‐producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals, Emerg Infect Dis, 9, 868, 10.3201/eid0907.030012 Yong, 2006, Increasing prevalence and diversity of metallo‐beta‐lactamases in Pseudomonas spp., Acinetobacter spp. and Enterobacteriaceae from Korea, Antimicrob Agents Chemother, 50, 1884, 10.1128/AAC.50.5.1884-1886.2006 Tsakris, 2006, VIM‐1 metallo‐β‐lactamase in Acinetobacter baumannii, Emerg Infect Dis, 12, 981, 10.3201/eid1206.051097 Fiett, 2006, Molecular epidemiology of acquired‐metallo‐β‐lactamase‐producing bacteria in Poland, Antimicrob Agents Chemother, 50, 880, 10.1128/AAC.50.3.880-886.2006